BHWM
TNXP icon

Beaird Harris Wealth Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Beaird Harris Wealth Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$6 – 656
2023
Q4 		– Hold
0
– – – 598
2023
Q3 		– Hold
0
– – – 454
2023
Q2 		– Hold
0
– – – 465
2023
Q1 		– Hold
0
– – – 479
2022
Q4 		– Hold
0
– – – 734
2022
Q3 		– Hold
0
– – – 530
2022
Q2 		– Hold
0
– – – 597
2022
Q1 		– Hold
0
– – – 580
2021
Q4 		– Hold
0
– – – 625

Other funds holding TNXP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return